$AMSC
AMERICAN SUPERCONDUCTOR CORP /DE/

2015 Q3 Form 10-Q Financial Statement

#000156459015009122 Filed on November 03, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q4 2014 Q3
Revenue $19.00M $21.25M $12.46M
YoY Change 52.58% 3.34% -48.49%
Cost Of Revenue $15.99M $18.09M $13.77M
YoY Change 16.14% 14.06% -39.1%
Gross Profit $3.012M $3.156M -$1.320M
YoY Change -328.18% -32.85% -184.08%
Gross Profit Margin 15.85% 14.85% -10.6%
Selling, General & Admin $6.773M $7.550M $8.050M
YoY Change -15.86% -8.28% -7.28%
% of Gross Profit 224.87% 239.23%
Research & Development $3.003M $2.795M $3.080M
YoY Change -2.5% -5.29% -0.1%
% of Gross Profit 99.7% 88.56%
Depreciation & Amortization $39.00K $39.00K $2.420M
YoY Change -98.39% -53.57% 2851.22%
% of Gross Profit 1.29% 1.24%
Operating Expenses $9.776M $10.35M $11.17M
YoY Change -12.48% -62.02% -68.28%
Operating Profit -$6.841M -$7.735M -$26.40M
YoY Change -74.09% 15.88% 139.39%
Interest Expense $300.0K $400.0K $500.0K
YoY Change -40.0% -75.0% -85.71%
% of Operating Profit
Other Income/Expense, Net -$397.0K -$209.0K $740.0K
YoY Change -153.65% -38.71% -216.54%
Pretax Income -$6.823M -$6.181M -$25.36M
YoY Change -73.1% -23.83% 77.57%
Income Tax $875.0K $172.0K $60.00K
% Of Pretax Income
Net Earnings -$7.698M -$6.353M -$25.42M
YoY Change -69.72% -24.52% 73.86%
Net Earnings / Revenue -40.51% -29.9% -204.12%
Basic Earnings Per Share -$0.57 -$0.72 -$3.12
Diluted Earnings Per Share -$0.57 -$0.72 -$3.12
COMMON SHARES
Basic Shares Outstanding 13.60M shares 8.764M
Diluted Shares Outstanding 13.60M shares 8.764M

Balance Sheet

Concept 2015 Q3 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.60M $36.00M $34.70M
YoY Change -6.05% 1.69% 33.98%
Cash & Equivalents $32.57M $35.98M $35.98M
Short-Term Investments
Other Short-Term Assets $11.60M $13.20M $13.70M
YoY Change -15.33% -36.84% -35.68%
Inventory $16.20M $26.54M $24.50M
Prepaid Expenses
Receivables $11.10M $10.78M $9.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.40M $86.51M $82.50M
YoY Change -13.45% -3.88% 1.85%
LONG-TERM ASSETS
Property, Plant & Equipment $52.70M $58.26M $60.40M
YoY Change -12.75% -13.31% -13.22%
Goodwill
YoY Change
Intangibles $1.565M
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.100M $2.833M $11.20M
YoY Change -18.75% -85.09% -42.86%
Total Long-Term Assets $62.90M $70.48M $73.30M
YoY Change -14.19% -20.27% -19.89%
TOTAL ASSETS
Total Short-Term Assets $71.40M $86.51M $82.50M
Total Long-Term Assets $62.90M $70.48M $73.30M
Total Assets $134.3M $157.0M $155.8M
YoY Change -13.8% -12.0% -9.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.803M $7.735M $7.063M
YoY Change -3.68% 49.38% 127.47%
Accrued Expenses $10.70M $27.20M $10.63M
YoY Change 0.65% 49.45% -45.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.900M $3.700M $4.800M
YoY Change -18.75% -75.97% -58.62%
Total Short-Term Liabilities $40.90M $65.85M $66.10M
YoY Change -38.12% 14.71% 20.08%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $4.900M $4.500M
YoY Change -55.56% -32.88% 114.29%
Other Long-Term Liabilities $3.800M $895.0K $3.900M
YoY Change -2.56% -64.2% 229.39%
Total Long-Term Liabilities $5.800M $895.0K $8.400M
YoY Change -30.95% -90.87% 609.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.90M $65.85M $66.10M
Total Long-Term Liabilities $5.800M $895.0K $8.400M
Total Liabilities $46.60M $74.51M $74.50M
YoY Change -37.45% 10.88% 24.86%
SHAREHOLDERS EQUITY
Retained Earnings -$901.7M
YoY Change
Common Stock $984.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $771.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $87.60M $82.48M $81.30M
YoY Change
Total Liabilities & Shareholders Equity $134.3M $157.0M $155.8M
YoY Change -13.8% -12.0% -9.69%

Cashflow Statement

Concept 2015 Q3 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$7.698M -$6.353M -$25.42M
YoY Change -69.72% -24.52% 73.86%
Depreciation, Depletion And Amortization $39.00K $39.00K $2.420M
YoY Change -98.39% -53.57% 2851.22%
Cash From Operating Activities -$4.730M -$9.560M -$5.860M
YoY Change -19.28% 166.3% 7.13%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K -$170.0K -$220.0K
YoY Change -50.0% 70.0% 1000.0%
Acquisitions
YoY Change
Other Investing Activities -$50.00K $2.260M $2.760M
YoY Change -101.81% 113.21% -990.32%
Cash From Investing Activities -$170.0K $2.100M $2.530M
YoY Change -106.72% 118.75% -866.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.100M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -980.0K 8.910M 1.470M
YoY Change -166.67% -25.87% -238.68%
NET CHANGE
Cash From Operating Activities -4.730M -9.560M -5.860M
Cash From Investing Activities -170.0K 2.100M 2.530M
Cash From Financing Activities -980.0K 8.910M 1.470M
Net Change In Cash -5.880M 1.450M -1.860M
YoY Change 216.13% -84.56% -72.89%
FREE CASH FLOW
Cash From Operating Activities -$4.730M -$9.560M -$5.860M
Capital Expenditures -$110.0K -$170.0K -$220.0K
Free Cash Flow -$4.620M -$9.390M -$5.640M
YoY Change -18.09% 169.05% 3.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
10188000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
10188000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6823000
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
79000
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
4909000
us-gaap Operating Income Loss
OperatingIncomeLoss
-39067000
us-gaap Costs And Expenses
CostsAndExpenses
63218000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
746000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7959000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7959000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1090000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1090000
us-gaap Inventory Write Down
InventoryWriteDown
829000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10426000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7767000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11369000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
310000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
514000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25361000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15369000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38749000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
190000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40029000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4901000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1834000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3099000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3464000
us-gaap Inventory Write Down
InventoryWriteDown
1285000
amsc Writeoff Prepaid Taxes
WriteoffPrepaidTaxes
511000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-356000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-410000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
207000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
343000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-921000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
860000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1196000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2264000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3478000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5283000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2957000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1533000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3337000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4154000
amsc Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
10188000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-762000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
16000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-2782000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-91000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
12000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-228000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2264000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
109000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3641000
amsc Proceeds From Issuance Follow On Public Offering
ProceedsFromIssuanceFollowOnPublicOffering
22281000
amsc Proceeds From Issuance Follow On Public Offering
ProceedsFromIssuanceFollowOnPublicOffering
4825000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
758000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2015Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
303
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
74000000
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22300000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1518000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.855
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
CY2015Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14054000
CY2014Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8305000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
12958000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8088000
CY2014Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
158000
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
150000
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
129000
CY2015Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
16016000
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12519000
CY2015Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
10204000
CY2015Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
8946000
CY2015Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
969000
CY2015Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
987000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54000
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
8820000
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
9411000
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1805000
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2117000
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3954000
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7487000
CY2015Q3 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
1571000
CY2015Q1 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
1581000
CY2015Q3 us-gaap Inventory Write Down
InventoryWriteDown
200000
CY2014Q3 us-gaap Inventory Write Down
InventoryWriteDown
600000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6803000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7062000
CY2015Q3 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
365000
CY2015Q1 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
1127000
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2931000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3254000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4102000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5960000
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
506000
CY2015Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
278000
CY2015Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3273000
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3934000
CY2015Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3344000
CY2014Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2855000
CY2014Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3207000
CY2015Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
429000
CY2014Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
974000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
423000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
903000
CY2015Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
500000
CY2014Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
462000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1084000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
743000
CY2014Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3367000
amsc Minimum Percentage Of Amount Being Realized Upon Ultimate Settlement
MinimumPercentageOfAmountBeingRealizedUponUltimateSettlement
0.50
CY2014Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
300000
CY2014Q3 us-gaap Severance Costs1
SeveranceCosts1
300000
us-gaap Severance Costs1
SeveranceCosts1
1400000
CY2015Q1 us-gaap Restructuring Reserve
RestructuringReserve
180000
us-gaap Restructuring Charges
RestructuringCharges
33000
us-gaap Payments For Restructuring
PaymentsForRestructuring
213000
CY2014Q1 us-gaap Restructuring Reserve
RestructuringReserve
844000
us-gaap Restructuring Charges
RestructuringCharges
1445000
us-gaap Payments For Restructuring
PaymentsForRestructuring
1509000
CY2014Q3 us-gaap Restructuring Reserve
RestructuringReserve
780000
CY2015Q3 us-gaap Interest Expense
InterestExpense
300000
us-gaap Interest Expense
InterestExpense
600000
CY2014Q3 us-gaap Interest Expense
InterestExpense
500000
us-gaap Interest Expense
InterestExpense
1000000
CY2015Q3 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
100000
amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
200000
CY2014Q3 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
200000
amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
300000
CY2012Q2 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2017-12-05
CY2013Q4 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2019-05-15
CY2014Q4 us-gaap Common Unit Issued
CommonUnitIssued
909090
CY2014Q4 amsc Warrants To Purchase One Share Of Common Stock
WarrantsToPurchaseOneShareOfCommonStock
0.9
CY2014Q4 amsc Number Of Warrants Issued To Purchase Common Stock
NumberOfWarrantsIssuedToPurchaseCommonStock
818181
CY2014Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.00
CY2015Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
9.41
CY2014Q4 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2019-11-13
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9100000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
700000
CY2014Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
3700000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4900000

Files In Submission

Name View Source Status
0001564590-15-009122-index-headers.html Edgar Link pending
0001564590-15-009122-index.html Edgar Link pending
0001564590-15-009122.txt Edgar Link pending
0001564590-15-009122-xbrl.zip Edgar Link pending
amsc-10q_20150930.htm Edgar Link pending
amsc-20150930.xml Edgar Link completed
amsc-20150930.xsd Edgar Link pending
amsc-20150930_cal.xml Edgar Link unprocessable
amsc-20150930_def.xml Edgar Link unprocessable
amsc-20150930_lab.xml Edgar Link unprocessable
amsc-20150930_pre.xml Edgar Link unprocessable
amsc-ex101_275.htm Edgar Link pending
amsc-ex102_277.htm Edgar Link pending
amsc-ex103_276.htm Edgar Link pending
amsc-ex311_9.htm Edgar Link pending
amsc-ex312_6.htm Edgar Link pending
amsc-ex321_7.htm Edgar Link pending
amsc-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20151103000328959157.jpg Edgar Link pending
g20151103000343479242.jpg Edgar Link pending
g20151103000348156331.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending